Samrat Pharmachem Reports Declining Profitability in August 2025 Financial Results
Samrat Pharmachem has announced its financial results for the quarter ending June 2025, revealing challenges in profitability. The company reported a decline in Profit After Tax and operating profit, with key metrics reaching their lowest levels in recent quarters, indicating a concerning trend in its financial health.
Samrat Pharmachem, a microcap company in the Pharmaceuticals & Biotechnology sector, has released its financial results for the quarter ending June 2025 on August 13, 2025. The company has reported a consistent performance over the past three months, with no changes in its evaluation score.The financial results indicate challenges for Samrat Pharmachem. The Profit After Tax (PAT) for the nine-month period stands at Rs 2.15 crore, reflecting a significant year-on-year decline. Additionally, the operating profit, measured as Profit Before Depreciation, Interest, and Taxes (PBDIT), has reached its lowest point in the last five quarters at Rs 0.12 crore. Furthermore, the Profit Before Tax (PBT), excluding other income, has also hit a low of Rs -0.48 crore during the same timeframe.
These figures suggest a concerning trend in the company's financial health, particularly in profitability metrics. As a result, there has been an adjustment in the evaluation of Samrat Pharmachem's performance.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
